CO-AMOXI Mepha pdr 156.25 mg p susp 100 ml
7680539820015
CH-53982
J01CR02
08.01.93
1 / 3
google
Details
- Product number
- 5398201
- CPT
- -
- Packaging group
- 100
- Unit
- ml
- Composition
- amoxicillinum anhydricum 125 mg ut amoxicillinum trihydricum, acidum clavulanicum 31.25 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aspartamum 8.32 mg, aromatica (Erdbeer) cum alcohol benzylicus et propylenglycolum, ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium max. 2.4 mg.
Articles (1)
Co-Amoxi-Mepha 156,25, Pulver zur Herstellung einer Suspension zum Einnehmen
Pulver zur Herstellung einer Suspension zum Einnehmen
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
31.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.32 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 18.80
Specialties list
Yes
Generic
Yes
SL addition date:
01/10/2000
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 53982
- Drug name
- Co-Amoxi-Mepha, Pulver zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- PULS
- ATC Code
- J01CR02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/03/2000
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.93
- Domain
- Human medicine
Packaging details
- Description (FR)
- CO-AMOXI Mepha pdr 156.25 mg p susp 100 ml
- Description (DE)
- CO-AMOXI Mepha Plv 156.25 mg f Susp 100 ml
- Market launch
- 10/03/2000
- Narcotic (BTM)
- No